GIANT CELL ARTERITIS STUDIES

If you are interested in any of our research studies, please contact our research group at 215-614-4417 or email us at rheumatologyresearch@uphs.upenn.edu

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc)

Medication involved: YES

Disease studied: GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN

Currently enrolling: YES

VCRC Genetic Repository One-Time DNA Study

Medication involved: NO

Disease studied: GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN

Currently enrolling: YES 

Researching Micro-Organisms in Large-Vessel Vasculitis (RESOLVE)

Medication involved: NO

Disease studied: GCA & Takayasu's arteritis

Currently enrolling: YES

Vessel Wall Enhancement in Giant Cell Arteritis (VEGA)

Medication involved: NO

Disease studied: GCA

Currently enrolling: YES

Tissue Repository Collection Protocol

Medication involved: NO

Disease studied: GPA, MPA, EGPA, GCA, Takayasu's arteritis, PAN, cutaneous vasculitis

Currently enrolling: YES

SELECT-GCA: Upadacitinib in Giant Cell Arteritis

Medication involved: YES

Disease studied: GCA

Currently enrolling: YES

A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in

Giant Cell Arteritis (ABAGART)

Medication involved: YES

Disease studied: GCA

Currently enrolling: YES